Blai Coll's most recent trade in Structure Therapeutics Inc - ADR was a trade of 284,241 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on March 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Structure Therapeutics Inc... | Blai Coll | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2025 | 284,241 | 284,241 | - | - | Employee Stock Option (right to buy) | |
| Structure Therapeutics Inc... | Blai Coll | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2025 | 116,988 | 219,588 | - | 0 | Ordinary Shares | |
| Structure Therapeutics Inc... | Blai Coll | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2025 | 363 | 728 | - | - | American Depositary Shares | |
| Structure Therapeutics Inc... | Blai Coll | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Sep 2024 | 111,000 | 111,000 | - | - | Share option (right to buy) | |
| Structure Therapeutics Inc... | Blai Coll | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Sep 2024 | 90,600 | 102,600 | - | 0 | Ordinary Shares |